Integrative analysis of drug response and clinical outcome in acute myeloid leukemia is a research paper published in Cancer Cell (2022). On theSindex it has a DataRank of 0. It has been cited 373 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: P30CA042014
University of Utah
Grant: 2400-13
National Cancer Institute
Grant: RSG-19-184-01 \u2013 LIB
National Cancer Institute
Grant: R00 5K99CA237630
National Cancer Institute
Grant: R01CA229875
National Cancer Institute
Grant: R01 CA247943
National Cancer Institute
Grant: U01CA217862
National Cancer Institute
Grant: R01CA214428
National Cancer Institute
Grant: U01CA214116
National Cancer Institute
Grant: U54CA224019
National Cancer Institute
Grant: F30CA239335
National Heart, Lung, and Blood Institute
Grant: R01HL155426
American Cancer Society
Grant: RSG-17-187-01-LIB
National Center for Advancing Translational Sciences
Grant: UL1TR002369
American Society of Hematology
Grant: K08 CA245224
NCI NIH HHS
Grant: R01 CA262758
European Hematology Association
Grant: TRTH171
NCI NIH HHS
Grant: K99 CA237630
NCI NIH HHS
Grant: U01 CA271412
NCI NIH HHS
Grant: R01 CA245002
NCI NIH HHS
Grant: P30 CA069533
National Institutes of Health
Grant: 1K08CA245224-01
Epigenetics of Mutation-Order in Acute Myeloid Leukemia
National Institutes of Health
Grant: 5F30CA239335-02
Defining the stromal landscape that sustains AML drug resistance
National Institutes of Health
Grant: 5R01CA245002-03
Targeting PTPN11 dependent Hematologic Malignancies
National Institutes of Health
Grant: 3UL1TR002369-04S2
Oregon Clinical and Translational Research Institute - The National COVID Cohort Collaborative (N3C)
National Institutes of Health
Grant: 1K99CA237630-01
Characterizing the pathogenesis and targeted therapeutics of Wilms' Tumor 1 (WT1) mutations in AML
National Institutes of Health
Grant: 5R01CA247943-03
Mechanisms of differentiation blockade in CSF3R-mutant AML
National Institutes of Health
Grant: 1R01CA262758-01
Mechanisms of venetoclax combination activity in acute myeloid leukemia
National Institutes of Health
Grant: 5R01HL155426-02
Hematopoiesis in germline RUNX1mutation carriers: impact of inflammation and the bone marrow niche
National Institutes of Health
Grant: 5U54CA224019-03
Tumor Intrinsic and Microenvironmental Mechanisms Driving Drug Combination Efficacy and Resistance in AML
National Institutes of Health
Grant: 3P30CA042014-30S2
Cancer Center Support Grant
National Institutes of Health
Grant: 5R01CA229875-03
Mechanisms and targeting of inflammatory cytokine-driven expansion and progression in AML
National Institutes of Health
Grant: 5U01CA214116-02
Proteogenomic Translational Research Center for Clinical Proteomic
National Institutes of Health
Grant: 1R01CA214428-01A1
An Academic-Industry Partnership to Advance Functional Genomics for Personalized Oncology.
National Institutes of Health
Grant: 5U01CA217862-03
Functional Genomic Discovery of Pathway Targeted and Immune Modulatory Therapeutic Combinations in Hematologic Malignancies
Iterion Therapeutics
Mark Foundation For Cancer Research
Oregon Health and Science University
Bristol-Myers Squibb
Gilead Sciences
Leukemia and Lymphoma Society
Servier
Agios Pharmaceuticals
Incyte
Novartis
Gabrielle's Angel Foundation for Cancer Research
Otago Medical Research Foundation
Silver Family Foundation
AbbVie
Pfizer
AstraZeneca
Howard Hughes Medical Institute
FWCI
47.34
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 1 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 2 of Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Additional file 2 of Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Additional file 1 of Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Additional file 3 of Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Additional file 1 of Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Additional file 3 of Deciphering genetic and nongenetic factors underlying tumour dormancy: insights from multiomics analysis of two syngeneic MRD models of melanoma and leukemia
Additional file 6 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 5 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 4 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 5 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 6 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 4 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 2 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 3 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 3 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia
Additional file 2 of Integration of transcription regulation and functional genomic data reveals lncRNA SNHG6’s role in hematopoietic differentiation and leukemia